Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nyxoah Ord Shs NYXH

Healthcare Medical Devices
Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every... see more

Recent & Breaking News (NDAQ:NYXH)

Nyxoah Announces Inaugural Investor & Analyst Meeting

GlobeNewswire February 21, 2023

Nyxoah Appoints Mr. Daniel Wildman to its Board of Directors

GlobeNewswire January 9, 2023

Information on the total number of voting rights and shares

GlobeNewswire December 29, 2022

Nyxoah Files Shelf Registration Statement and Announces At-the-Market Equity Offering Program

GlobeNewswire December 22, 2022

Nyxoah to Participate in the Piper Sandler 34th Annual Healthcare Conference

GlobeNewswire November 17, 2022

Nyxoah Reports Third Quarter 2022 Financial and Operating Results

GlobeNewswire November 8, 2022

Nyxoah Announces Change to Board of Directors

GlobeNewswire October 24, 2022

Nyxoah to Participate in the Jefferies London Healthcare Conference

GlobeNewswire October 20, 2022

Nyxoah to Release Third Quarter Financial Results on November 8, 2022

GlobeNewswire October 18, 2022

Information on the total number of voting rights and shares

GlobeNewswire September 30, 2022

Nyxoah to Participate in the 17th Annual Wells Fargo Securities Healthcare Conference

GlobeNewswire August 18, 2022

Nyxoah Reports Second Quarter and First Half 2022 Financial and Operating Results

GlobeNewswire August 8, 2022

Nyxoah and Acurable Enter into Distribution Agreement in Germany for the AcuPebble SA100 Home Sleep Test

GlobeNewswire August 2, 2022

Nyxoah to Present at the Canaccord Genuity 42nd Annual Growth Conference

GlobeNewswire July 27, 2022

Nyxoah to Release Second Quarter and First Half 2022 Financial Results on August 8, 2022

GlobeNewswire July 19, 2022

Nyxoah Announces CE Mark Approval for Genio® 2.1

GlobeNewswire July 18, 2022

Nyxoah Receives FDA IDE Approval to Initiate the ACCCESS Study of Genio® in Complete Concentric Collapse Patients

GlobeNewswire July 11, 2022

Information on the total number of voting rights and shares

GlobeNewswire June 30, 2022

Nyxoah Joins the Euronext Tech Leaders Initiative, Included in the Euronext Tech Leaders Index

GlobeNewswire June 7, 2022

FDA Approves Genio® 2.1 For Use in DREAM U.S. IDE Pivotal Study

GlobeNewswire June 1, 2022